ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 815,92
-1,49%
DAX
17 932,17
-1,10%
Brent Oil
85,935
-1,55%
Bitcoin
59 820,45
-6,29%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Arrowhead Pharmaceuticals Inc (ARWR)

  7. Arrowhead Pharmaceuticals Inc (ARWR) Actualités

ARWR Arrowhead Pharmaceuticals Inc

22,62
-0,51 (-2,20%)
Après les heures de négociation
Dernière mise à jour : 22:02:15
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Arrowhead Pharmaceuticals Inc ARWR NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,51 -2,20% 22,62 22:02:15
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
22,76 22,59 23,17 22,65 23,13
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
16/4/202415:00GLOBETurnstone Biologics Appoints William Waddill to its Board of..
08/3/202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:30EDGAR2Form 144 - Report of proposed sale of securities
27/2/202423:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/2/202422:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/2/202422:07EDGAR2Form 8-K - Current report
02/2/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:57EDGAR2Form 144 - Report of proposed sale of securities
26/1/202423:28EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/1/202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:22EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
17/1/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202422:16EDGAR2Form 144 - Report of proposed sale of securities
11/1/202422:48EDGAR2Form 144 - Report of proposed sale of securities
11/1/202422:38EDGAR2Form 144 - Report of proposed sale of securities
11/1/202422:22EDGAR2Form 144 - Report of proposed sale of securities
11/1/202422:05EDGAR2Form 144 - Report of proposed sale of securities
08/1/202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202401:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202423:33EDGAR2Form 144 - Report of proposed sale of securities
05/1/202423:14EDGAR2Form 144 - Report of proposed sale of securities
05/1/202422:58EDGAR2Form 144 - Report of proposed sale of securities
05/1/202422:39EDGAR2Form 144 - Report of proposed sale of securities
05/1/202422:21EDGAR2Form 144 - Report of proposed sale of securities
05/1/202422:08EDGAR2Form 144 - Report of proposed sale of securities
04/1/202423:27EDGAR2Form 8-K - Current report
04/1/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/1/202419:49EDGAR2Form 144 - Report of proposed sale of securities
04/1/202419:25EDGAR2Form 144 - Report of proposed sale of securities
04/1/202419:06EDGAR2Form 144 - Report of proposed sale of securities
04/1/202418:24EDGAR2Form 144 - Report of proposed sale of securities
02/1/202422:44EDGAR2Form 144 - Report of proposed sale of securities
22/12/202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202322:34EDGAR2Form 144 - Report of proposed sale of securities
19/12/202322:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202321:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202321:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202321:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202321:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202321:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202323:16EDGAR2Form 8-K - Current report
29/11/202322:10EDGAR2Form 8-K - Current report
29/11/202322:09EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..

Dernières Valeurs Consultées

NASDAQ
ARWR
Arrowhead Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés